Global Lab Automation in Genomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Global Lab Automation in Genomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Global Lab Automation in the Genomics market is expected to grow by registering a CAGR of 7.5% during the forecast period. There has been a significant improvement in understanding of genome sequencing in terms of data analytics advances that reveal unknown correlations, hidden patterns, and other insights, especially when testing data sets on a large scale. This is due to technological advancements and increasing computational capacities driving the market.

Key Highlights

• The development of genomics, which uses the availability of whole DNA sequences for entire organisms, is due to the innovative work of a few genomics giants and the more recent next-generation sequencing technology.
• The speed, volume, and price of genome sequencing have all dramatically increased because of the development of next-generation sequence technologies. Additionally, hundreds of life-science databases and programs that promote scientific study have been made possible because of advancements in bioinformatics. These databases make it simple to search, contrast and analyze the information that is organized and kept there.
• Furthermore, significant medical advancements are occurring quickly, mostly due to recent improvements in genomic analysis. DNA sequence analysis clarifies how genetic diversity causes disease and ultimately results in novel treatments. Additionally, laboratory automation has opened space for innovative flexibility, increased throughput, and cost-effective solutions. It allows for quick handling and enables the process to be sped up without worrying about accuracy and dependability. Due to the low cost of genotyping and DNA sequencing, the expansion rate is strong.
• Genetic testing start-ups have been springing up like daisies due to improvements in DNA sequencing technology that have made it more affordable and widely available. However, the knowledge of whole genomes has made functional genomics viable, particularly interested in gene expression patterns under various situations, making it possible for genome sequencing programs to increase rapidly in breadth and speed. The most important tools, in this case, are microarrays and bioinformatics.
• Nucleic acid isolation, RNAi screening, CRISPR analysis, PCR, and gene expression analysis are just a few of the genomics applications that use automation. Laboratory automation players/vendors are developing tools to meet these application requirements. For example, Tecan Group introduced its new "Fluent Automation Workstation" platform in July 2021, which incorporates a variety of capabilities to simplify day-to-day laboratory automation and increase workflow productivity. During a run, the system reacts dynamically, adjusting based on actual times to maintain continuous optimal throughput, all of which are visible in real-time via an easy-to-understand Gantt chart.
• The companies are developing new products or incorporating new features in the existing products to meet the needs of the customer. For instance, in March 2022, Firefly, a revolutionary liquid handling platform for next-generation sequencing (NGS) library preparation, has been launched by SPT Labtech, a pioneer in designing and developing automated apparatus and consumables for life science applications. Firefly changes NGS liquid handling operations by combining pipetting and dispensing inside a small all-in-one design, paving the path for a new age of genomics laboratory automation. With numerous user levels, clever programming, and a fully visible audit trail, the platform establishes a new standard in sophisticated, intuitive liquid handling software and hardware capabilities.
• The COVID-19 pandemic has highlighted the difficulties of high-throughput molecular testing, necessitating a more integrated method to satisfy workload demands without sacrificing results quality and various partnerships are witnessed in the market focusing on molecular testing. For instance, in February 2021, Tecan, a products, services, and solutions provider for lab processes and medical procedures, and UgenTec, a laboratory software company, announced a partnership to produce fully integrated sample-to-result PCR workflow solutions. Tecan's liquid handling and automation capabilities will be combined with UgenTec's FastFindersoftware, combining end-to-end automation with extensive data analysis and workflow tools to provide high throughput molecular testing solutions.

Key Market TrendsAutomated Liquid Handlers to Witness High Growth

• In the genomics lab, cross-contamination is a significant issue that can be prevented by employing automated systems to manage the reagents and reaction mixtures. It is thought that eliminating human intervention leads to more consistency. Numerous technological developments in the plastics molding industry have decreased the number of chemicals needed and made it easy to handle smaller volumes of liquid. These developments have made it easier to create micro- and nanoliter plates that can work with automated liquid handling machinery.
• Industry innovators have established the standard to create automated liquid handlers. To boost process productivity, these businesses consistently invest in designing quality products. As an illustration, Agilent's adaptable and space-saving automated liquid handling systems allow for streamlined sample preparation with consistently high accuracy. While retaining repeatability, automation enables labs to run more samples and free up manual labor.
• Additionally, the quick expansion of several clinical and pre-clinical trials across the globe, mostly in the US, has made the requirement for speed in sample analysis essential. The machines operate nonstop in clinical research and require sizable personnel to maintain proper operation. Additionally, the demand for early treatments and diagnostics grows as new diseases are discovered and old ones spread quickly. This is anticipated to accelerate the adoption of automated liquid handlers by raising the rate at which clinical diagnostic applications are made.
• Automated liquid handling robots disperse and sample liquids in tubes or wells and are frequently integrated as mechanical injection modules as the front end of liquid chromatographic systems. This kind of equipment can also include automated pipetting systems and microplate washers. These essential labor-saving tools provide accurate sample preparation for various bioassays, liquid or powder weighing, sample preparation, and high throughput screening/sequencing (HTC).
• The life science industry, in terms of automated liquid handlers, automated plate handlers, and robotic arms, among others, has had the third-highest growth in industrial robots, according to the Robotic Industries Association, to fulfill the demand.

North America Occupies the Largest Market Share

• North America has been a pioneer in clinical research for years. This region is home to some of the major pharmaceutical companies, like Pfizer, Novartis, GlaxoSmithKline, J&J, and Novartis. The region also has the highest concentration of contract research organizations (CROs). Some of the significant CROs are Laboratory Corp. of America Holdings, IQVIA, Syneos Health, and Parexel International Corp. ​
• Owing to the presence of all the major players in the industry and stringent FDA regulations, the market is very competitive in the region. To gain an advantage over competitors, the genomics research organizations in the region are increasingly adopting robotics and automation in labs.
• The genomic industry, especially in the United States is still in its growing phase and is expected to grow at a fast pace over the coming years. The availability of new genome sequencing technologies, well-established healthcare infrastructure, and increasing geriatric population are significant contributing factors toward revenue growth of the market.
• In the United States, the need to accommodate growth and the drive to boost efficiency are priming blood centers to acquire fully automated walkaway systems, either to perform types and screens or to test specimens for infectious diseases or both.​
• The US genomic industry is expected to grow at a fast pace over the coming years. The availability of new genome sequencing technologies, well-established healthcare infrastructure, and increasing geriatric population are significant contributing factors toward revenue growth of the market. Additionally, the demand for precision medicines is rising in the country.

Competitive Landscape

Lab automation in the genomics market is competitive, owing to many small and big players exporting products to many countries. The key strategies adopted by the major players are technological advancement in development, partnerships, and merger and acquisition. Some of the major players in the market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, PerkinElmer, and others.

• April 2021 - Thermo Fisher Scientific Inc. unveiled their new Collaborative lab automation platform "inSPIRE," which gives users a fully interactive and user-friendly experience. This platform provides a scalable solution for laboratories wishing to reap the benefits of automated processes in terms of throughput, reproducibility, and efficiency.
• March 2021 - Beckman Coulter Life Sciences introduced "the Biomek NGeniuS workstation," its newest automated liquid handler. The Biomek NGeniuS workstation is built exclusively for NGS library preparation, reducing manual transfers and hands-on time in the usually time-consuming process of library development.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.